BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
8.09
+0.54 (7.15%)
At close: Dec 24, 2025, 1:00 PM EST
8.33
+0.24 (2.92%)
After-hours: Dec 24, 2025, 4:55 PM EST
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,794,204
Market Cap
15.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 7 days ago - “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine - GlobeNewsWire
- 15 days ago - BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - GlobeNewsWire
- 16 days ago - BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - GlobeNewsWire
- 23 days ago - BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - GlobeNewsWire
- 4 weeks ago - BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 - GlobeNewsWire
- 5 weeks ago - BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics - GlobeNewsWire
- 5 weeks ago - BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025 - GlobeNewsWire
- 6 weeks ago - BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 - GlobeNewsWire